Recro Pharma, Inc. Business Operations Contracts & Agreements
11 Contracts & Agreements
- Development Agreements (4 contracts)
- Sales Agreements (1)
- Services Agreements (3)
- Supply Agreements (3)
- Manufacturing and Supply Agreement, dated as of February 8, 2019, by and between Recro Pharma, Inc. and Novartis Pharma AG (Filed With SEC on March 6, 2019)
- Sales Agreement, dated as of December 29, 2017, by and between Recro Pharma, Inc. and Cowen and Company, LLC (Filed With SEC on December 29, 2017)
- Master Manufacturing Services Agreement, dated July 14, 2017, by and between Patheon UK Limited and Recro Ireland Limited (Filed With SEC on August 11, 2017)
- Third Amendment to the Development, Manufacturing and Supply Agreement, dated June 15, 2017, by and between Alkermes Pharma Ireland Limited and Recro Pharma, Inc (Filed With SEC on August 11, 2017)
- Second Amendment to Development, Manufacturing and Supply Agreement (Filed With SEC on March 9, 2017)
- First Amendment to Development, Manufacturing and Supply Agreement (Filed With SEC on March 9, 2017)
- SUPPLEMENTAL AGREEMENT NO. 2 TO THE AMENDED AND RESTATEDLICENSE AND SUPPLY AGREEMENT (GENERIC VERAPAMIL) (Filed With SEC on August 14, 2015)
- Date: 26 June2003 ELAN CORPORATION, PLC. AND WATSON LABORATORIES, INC. AMENDED AND RESTATED LICENCEAND SUPPLY AGREEMENT (VERAPAMIL) (Filed With SEC on August 14, 2015)
- DEVELOPMENT, MANUFACTURING AND SUPPLY AGREEMENT BETWEEN ALKERMES PHARMA IRELAND LIMITED AND RECRO PHARMA, INC. (Filed With SEC on August 14, 2015)
- Amendment #1 to Office Services Agreement (Filed With SEC on November 29, 2013)
- OFFICE SERVICES AGREEMENT (Filed With SEC on November 29, 2013)